Dose-dependent role of claudin-1 in vivo in orchestrating features of atopic dermatitis
-
- Reitaro Tokumasu
- Laboratory of Biological Science, Graduate School of Frontier Biosciences and Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan;
-
- Kosuke Yamaga
- Laboratory of Biological Science, Graduate School of Frontier Biosciences and Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan;
-
- Yuji Yamazaki
- Laboratory of Biological Science, Graduate School of Frontier Biosciences and Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan;
-
- Hiroyuki Murota
- Department of Dermatology, Course of integrated Medicine, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan;
-
- Koya Suzuki
- Laboratory of Biological Science, Graduate School of Frontier Biosciences and Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan;
-
- Atsushi Tamura
- Laboratory of Biological Science, Graduate School of Frontier Biosciences and Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan;
-
- Kana Bando
- Laboratory for Animal Resources and Genetic Engineering, RIKEN Center for Developmental Biology, 2-2-3 Minatojima Minami-machi, Chuou-ku, Kobe 650-0047, Japan
-
- Yasuhide Furuta
- Laboratory for Animal Resources and Genetic Engineering, RIKEN Center for Developmental Biology, 2-2-3 Minatojima Minami-machi, Chuou-ku, Kobe 650-0047, Japan
-
- Ichiro Katayama
- Department of Dermatology, Course of integrated Medicine, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan;
-
- Sachiko Tsukita
- Laboratory of Biological Science, Graduate School of Frontier Biosciences and Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan;
説明
<jats:title>Significance</jats:title><jats:p><jats:italic>Claudin-1</jats:italic>(<jats:italic>CLDN1</jats:italic>), which is thought to be a key gene for human skin disease, especially atopic dermatitis (AD), encodes the dominant claudin responsible for the paracellular barrier at tight junctions in the epidermis. Although decreased<jats:italic>CLDN1</jats:italic>expression levels are reported in AD patients, it has been difficult to study how CLDN1 contributes to AD development, mainly because<jats:italic>Cldn1</jats:italic>knock-out mice die within 1 d after birth from dehydration. In this report, we reproduced features of human AD in mice, by systematically regulating the<jats:italic>Cldn1</jats:italic>expression level. Our experimental approach contributes to the understanding of AD’s etiology and suggests a therapeutic target for this disorder.</jats:p>
収録刊行物
-
- Proceedings of the National Academy of Sciences
-
Proceedings of the National Academy of Sciences 113 (28), E4061-, 2016-06-24
Proceedings of the National Academy of Sciences
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360567183915815808
-
- ISSN
- 10916490
- 00278424
-
- データソース種別
-
- Crossref
- KAKEN